skin cancer

Charles Stiefel was committed to the Foundation and dermatology researchers.

Remembering Charles W. Stiefel (1950–2023)

The Foundation is indebted to Charles and Daneen Stiefel for their generosity and we are grateful for their conviction in the value of our work.

The Melanoma Epidemic: Real or Illusory

In 2023, the United States Preventive Services Task Force determined there was insufficient evidence to assess the balance of benefits and harms of screening for melanoma using a whole-body skin examination in the primary care setting in part due to the lack of randomized controlled studies. Such studies addressing the mortality benefit of screening for skin cancer would be a massive undertaking. On a practical level, there are not enough dermatologists in the country to screen all American adults for skin cancer.

Dermatofibrosarcoma

NCCN recommends Mohs as the first-line therapy for DFSP